Thrombolytic therapy for acute arterial occlusion

Area of Science:

• Vascular Surgery
• Interventional Radiology
• Pharmacology

Background:

• Standard treatment for peripheral arterial occlusion involves surgery like embolectomy or bypass grafting.
• Intra-arterial thrombolysis is an alternative initial intervention to identify the underlying cause of occlusion.
• Four thrombolytic agents are available: streptokinase, urokinase, recombinant tissue plasminogen activator, and acylated plasminogen streptokinase activator complex.

Purpose of the Study:

• To evaluate the role and efficacy of intra-arterial thrombolysis in managing acute peripheral arterial occlusion.
• To compare thrombolytic therapy outcomes with traditional surgical interventions.

Main Methods:

• Review of recent randomized clinical trials comparing thrombolytic therapy with immediate open surgical intervention.
• Analysis of patient survival and amputation rates in different treatment groups.

Main Results:

• Thrombolytic therapy demonstrated improved patient survival in the initial management of acute peripheral arterial occlusion.
• Amputation rates were similar between thrombolytic therapy and immediate open intervention groups.
• Urokinase is currently the most frequently used thrombolytic agent.

Conclusions:

• Thrombolytic therapy offers potential benefits, including improved survival, for acute peripheral arterial occlusion.
• The optimal choice of treatment modality (thrombolysis vs. surgery) may depend on specific patient characteristics.
• Further large-scale clinical trials are needed to determine the best treatment strategies for various patient subgroups.